drugset / Trial / NCT01261611
Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical Dystonia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate how well a new drug called Dysport NG works and how safe it is, when it is used for the treatment of cervical dystonia. Dysport NG will be compared to an approved drug called Dysport.
Timeline
- Start
- 2011-04
- Primary completion
- 2012-05
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 250 iu | Intramuscular |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 500 iu | Intramuscular |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 750 iu | Intramuscular |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 1000 iu | Intramuscular |